MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Impact of a Structured Patient Education Module on Knowledge of Botulinum Toxin Therapy, Goal Attainment, and Treatment Satisfaction in Cervical Dystonia

    K. Katawatee, R. Bhidayasiri, P. Panyakaew (Bangkok, Thailand)

  • Impact of Alpha-Synuclein Burden and Cellular Stress on GBA-PD Macrophage

    V. Lentini, G. Uras, D. Moreno-Martinez, S. Lucas, A. Pantaleo, D. Hughes (London, United Kingdom)

  • Impact of Amyloid-beta co-pathology on future hallucination in Parkinson’s disease

    M. Park (Gwangmyeong, Republic of Korea)

  • Impact of Caffeine Consumption on Clinical Phenotype and Non-Motor Symptoms in Parkinson’s Disease

    A. Rekik, M. Abid, R. Guizani, K. Jemai, A. Mili, H. Slimene, A. Hassine, S. Naija, S. Ben Amor (Sousse, Tunisia)

  • Impact of Comorbidities on Clinical Outcomes and Socioeconomic Burden in Parkinson’s Disease: A 10-Year Nationwide Cohort Study

    JS. Park, HT. Kim (Busan, Republic of Korea)

  • Impact of Continuous Subcutaneous Foslevodopa/Foscarbidopa (FLC/FCD) on Non-Motor Symptom Burden in Advanced Parkinson’s Disease: Domain-Level Analysis

    K. Waqar, M. Thomas, Y. Abdelmajid, E. Freitas, R. Cabrito, RH. Battah, A. Anjum, SH. Mittal (Abu Dhabi, United Arab Emirates)

  • Impact of Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion on Neuropsychiatric Symptoms in Clinical Practice: A Multicenter Study

    D. Campo-Caballero, J. Rodríguez-Antigüedad, A. Puig-Davi, J. Ruiz-Martinez, A. Vinagre-Aragón, E. Mondragón, L. Pardina, G. González-Ortega, D. Santos-García (San Sebastian, Spain)

  • Impact of foslevodopa/foscarbidopa infusion on autonomic symptoms in advanced Parkinson’s Disease

    D. Rinaldi, L. de Carolis, E. Bianchini, S. Galli, M. Salvetti (Rome, Italy)

  • Impact of Helicobacter pylori Eradication on MDS-UPDRS Part III Motor Score in Patients With Parkinson’s Disease A Prospective Cohort Study in Northern Mexico

    S. Murillo Quintana, D. Sanchez Galvan (Torreon, Mexico)

  • Impact of Hula on Balance Outcomes in Parkinson’s Disease

    M. Yee, P. Young, R. Shuman, C. Stickley, M. Bruno (Honolulu, USA)

  • « Previous Page
  • 1
  • …
  • 100
  • 101
  • 102
  • 103
  • 104
  • …
  • 208
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley